Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Curis Lifesciences Financial Results

Curis Lifesciences Limited approved its audited standalone financial results for the year ended March 31, 2026. The results provide essential year-end performance data for investors.

Source

NSE filing, NSE: CURIS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Curis Lifesciences Ltd: key numbers

Share price
₹181.50
Market cap
₹146.7 Cr
Revenue (annual)
₹60.63 Cr
Net profit (annual)
₹6.92 Cr
P/E (TTM)
21.2×Sector 46.1×
Promoter holding
68.03%
FII holding
1.05%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Curis Lifesciences Ltd

All →

Other financial results announcements

All →